Tag:
Corcept Therapeutics
Latest Headlines
Latest Headlines
Rare-disease drugs won't help out-of-work pharma reps
As drugmakers turn their focus to rare-disease drugs, armies of sales reps become unnecessary.
Corcept skyrockets on FDA nod for rare disease drug
U.S. regulators have green-lighted Corcept Therapeutics ' drug Korlym (mifepristone), the first FDA-approved treatment for Cushing's syndrome.
Corcept shares jump on promising PhIII data
Shares of Corcept Therapeutics shot up after the developer announced it had reaped some promising top-line data points from its Phase III study of a new drug for Cushing's syndrome, leaving the Menlo
